| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | Anavex Life Sciences Corp. | Dec 12, 2022 | |
| Buy | Anavex Life Sciences Corp. | Oct 12, 2022 |
This page tracks congressional stock trading activity in Anavex Life Sciences Corp. (AVXL) in the Healthcare sector. Disclosed Capitol has indexed 2 disclosed congressional trades involving AVXL. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of January 2023 — Disclosed Capitol has tracked 2 disclosed congressional trades in Anavex Life Sciences Corp. (AVXL) — 1 sells with no recorded buys — led by Christopher L. Jacobs (R).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Dec 12, 2022 | Christopher L. Jacobs | R | Sale | $1,001 - $15,000 |
| Oct 12, 2022 | Christopher L. Jacobs | R | Buy | $1,001 - $15,000 |
Across the 2 disclosed congressional trades in Anavex Life Sciences Corp. (AVXL), members of Congress have reported 0 buys and 1 sell. The average 30-day alpha vs. the S&P 500 is -1.07%.
For fiscal year 2025, Anavex Life Sciences Corp. reported net income of -$47.5M, per SEC filings.
Most recent reported quarter: Q3 FY2026 — revenue —, net income $7.8M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.